A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

This is “bigger” than the ChatGPT moment, Lieberman wrote to me. “But Pandora’s Box hasn’t been opened for the rest of the ...

Author Shawn Peters blends clarity and rigor to make data structures and algorithms accessible to all learners. COLORADO, CO, UNITED STATES, January 2, 2026 /EINPresswire.com/ — Vibrant Publishers ...

2026 is highlighted as the year of the singularity with Elon Musk warning of underestimated impacts; conversations with him ...

Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.

2025 has come and gone. It was an interesting year and had its fair share of weird Vancouver stories. We’ve gone through some posts from throughout the year and selected some of the weirdest and ...

For quantum computers to outperform their classical counterparts, they need more quantum bits, or qubits. State-of-the-art ...

AI models are getting so good at finding vulnerabilities that some experts say the tech industry might need to rethink how ...

“I was curious to establish a baseline for when LLMs are effectively able to solve open math problems compared to where they ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...